2nd Annual European Congress on Genitourinary Malignancies™

2nd Annual European Congress on Genitourinary Malignancies™

20-21 April 2018
Madrid, Spain

Program Overview

Over the past decade or so, tremendous progress in the treatment of genitourinary (GU) cancers has led to improved outcomes for patients, but has also made clinical management of these malignancies more complex. We are excited to announce the 2nd Annual European Congress on Genitourinary Cancers™, a comprehensive educational conference designed to help practitioners place emerging information into the context of landmark clinical trial data and established standards of care, ultimately improving the care they provide to their patients with GU cancers.

This practical and interactive multiday program features a faculty of leading international experts who will provide up-to-date information and guidance via didactic lectures, question-and-answer sessions, and extended interactive case-based panel discussions. This format will enable participants to engage the faculty in a direct exchange of perspectives, personal experiences, and strategies related to clinical challenges in the management of GU cancers. In addition to focusing on key clinical topics and controversies, the program will include an exploration of emerging data on various therapeutic combinations and sequences undergoing clinical trial evaluation.

This meeting is not to be missed! The activity is sure to continue the legacy and tradition of Physicians’ Education Resource®, LLC, in providing clinicians with the knowledge and confidence to maintain state-of-the-art care and to optimize outcomes for patients with cancer.

Target Audience:

This educational activity is intended for medical, surgical, and radiation oncologists, as well as other healthcare professionals involved in the treatment and management of patients with genitourinary (GU) malignancies.

Educational Objectives:

At the conclusion of this activity, participants should be better prepared to:

  • Describe methods to stratify risk and apply tumor information to inform clinical decision making in the management of genitourinary (GU) malignancies
  • Summarize clinical trial evidence and recommendations that shape evolving strategies to care for patients with GU malignancies
  • Evaluate recent practice-changing clinical trial data concerning novel compounds or strategies to manage GU malignancies
  • Discuss how emerging clinical concepts and findings in the management of GU malignancies fit into evolving treatment paradigms in the field

Become a Member

Forgot Password?
Calendar of Events
Filter By